Newstral
Christopher Raymond
- BYear's Biggest Healthcare Conference Starts With Lots of Deals, No Blockbuster M&A2 min readbarrons.com
- Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sectoramny.com
- HSTORAGE SALEhealthcitysun.com
- BAbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown.3 min readbarrons.com
- BEarly Sales of Biogen's Alzheimer Drug Remain Unclear3 min readbarrons.com
- BBiogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says2 min readbarrons.com
- BBiogen Stock Can Go 'Decisively Higher' on Sales of Alzheimer's Drug2 min readbarrons.com
- BBiogen’s Alzheimer’s Drug Opens Up a New Market. These Stocks Could Benefit.4 minbarrons.com
- BBiogen Stock Jumps on FDA Approvalbarrons.com
- BBiogen Stock Is Falling Because Earnings Guidance Came Up Shortbarrons.com
- BThe FDA Delayed Its Decision on Biogen’s Alzheimer’s Drug. The Stock Is Up 10%.barrons.com
- BRegeneron Inks Deal to Sell Covid-19 Treatment to U.S., Even as Usage Lagsbarrons.com
- [Webinar] #EpicCRMFails Webinar Series Part 2: Epic Fails - and How to Avoid Them - January 27th, 11:30 am ETjdsupra.com
- BRegeneron Stock Climbs as Earnings Come in Strongbarrons.com
- BAbbVie Beats Earnings Expectations but Stock Falls Anywaybarrons.com
- Police logs - June 11, 2020The Day
- N‘A new era’: First peanut allergy drug for children, teens approved by U.S. regulatorsnationalpost.com
- BBiogen Stock Gets a Lift From Strong Earnings Reportbarrons.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.